Liquid chromatography-tandem mass spectrometry quantification of globotriaosylceramide in plasma for long-term monitoring of Fabry patients treated with enzyme replacement therapy (Q45129970)

From Wikidata
Jump to navigation Jump to search
scientific article published on 28 October 2004
edit
Language Label Description Also known as
English
Liquid chromatography-tandem mass spectrometry quantification of globotriaosylceramide in plasma for long-term monitoring of Fabry patients treated with enzyme replacement therapy
scientific article published on 28 October 2004

    Statements

    Liquid chromatography-tandem mass spectrometry quantification of globotriaosylceramide in plasma for long-term monitoring of Fabry patients treated with enzyme replacement therapy (English)
    Bryant C Nelson
    Crystal C C Sung
    Shaparak Araghi
    Dennis Wilkens
    X Kate Zhang
    John J Thomas
    Susan M Richards
    28 October 2004
    237-240

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit